2004
DOI: 10.1016/j.archoralbio.2004.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjögren’s syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
1

Year Published

2006
2006
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(21 citation statements)
references
References 43 publications
0
20
0
1
Order By: Relevance
“…Our three examinations (light immunohistochemical, confocal laser microscopic, and electron microscopic) showed that some lymphocytes were also IR for NPY and SP, suggesting that in inflammation these cells produce these neuropeptides and they are active in local immune responses of the stomach. Previously it was demonstrated in other tissues that certain conditions, e.g., inflammation, can induce the secretion and release of different neuropeptides from immunocytes (lymphocytes, macrophages, eosinophils) [18, [38][39][40]. Human monocytes and lymphocytes express the SP gene at both the mRNA and the protein level [41,42], as well as CGRP [43].…”
Section: Discussionmentioning
confidence: 99%
“…Our three examinations (light immunohistochemical, confocal laser microscopic, and electron microscopic) showed that some lymphocytes were also IR for NPY and SP, suggesting that in inflammation these cells produce these neuropeptides and they are active in local immune responses of the stomach. Previously it was demonstrated in other tissues that certain conditions, e.g., inflammation, can induce the secretion and release of different neuropeptides from immunocytes (lymphocytes, macrophages, eosinophils) [18, [38][39][40]. Human monocytes and lymphocytes express the SP gene at both the mRNA and the protein level [41,42], as well as CGRP [43].…”
Section: Discussionmentioning
confidence: 99%
“…In fact, both of these neuromediators are present in the lacrimal gland, and changes in their concentration have been demonstrated in the salivary glands of patients with Sjö gren syndrome. 21 A decrease in the circulating levels of NPY also has been described in patients affected by autoimmune diseases, which is in line with the anti-inflammatory role of this neuropeptide. 18,25 In fact, NPY treatment is known 19 to inhibit experimental autoimmune encephalomyelitis, a model of helper T-cell type 1-driven disease, by inhibiting helper T-cell type 1-driven inflammatory responses.…”
Section: Commentmentioning
confidence: 93%
“…[21][22][23][24] These changes are hypothesized to be a cause of salivary fluid flow decrease during Sjö gren syndrome. In fact, a remarkable discrepancy can be observed between the inflammatory involvement of the glands and the decrease in fluid flow.…”
mentioning
confidence: 96%
“…Stimulation of postganglionar parasympathetic fibres activates the release of acetylcholine together with other transmitters such as substance P, VIP, and ATP. Sympathetic fibres release norepinephrine, NPY, and ATP [136]. Substance P and CGRP co-localize in the ganglia [137].…”
Section: Sjögren Syndromementioning
confidence: 99%